NCT06195306 2026-04-13
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
9 trialsNCT03598309 2026-02-27
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT04268134 2024-02-29
ALTA
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT03831698 2023-06-01
Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
University of Kansas Medical Center
Phase 2 Unknown
NCT04907864 2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2 Unknown
NCT01661764 2018-06-08
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Vanderbilt University Medical Center
Phase 2 Completed
NCT01252290 2016-12-16
Breast Cancer Risk Biomarkers in Postmenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT01252277 2016-07-21
Breast Cancer Risk Biomarkers in Premenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT00930527 2014-07-23
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Columbia University
Phase 2 Terminated